| < back to ASX Corporate Governance |
1. Introduction 1.1 The shares of Eyecare Partners Limited (Company) are (or are to be) quoted on ASX Limited (ASX). 1.2 Under the ASX Listing Rules a company must continuously disclose price-sensitive information to the market. Price-sensitive information is information that a reasonable person would expect to have a material effect on the price or value of a company's securities. 1.3 The disclosure obligation is given legislative force under the Corporations Act 2001 (Cth) (Act). 1.4 The Group is committed to complying with the continuous disclosure obligations contained in the ASX Listing Rules and the Act 1.5 This protocol embraces the principles contained in the ASIC guidance note Better Disclosure for Investors, ASX Guidance Note 8 and the Principles of Good Corporate Governance and Best Practice Recommendations published by the ASX Corporate Governance Council. 2. Defined terms In this protocol: Company Securities includes shares in the Company or a Group member, options over those shares and any other financial products of the Group traded on ASX. Disclosure Officer means the Company Secretary. Group means the Company and its controlled entities. 3. Objective 3.1 The objective of this protocol is to: (a) ensure the Company immediately discloses all price-sensitive information to ASX in accordance with the ASX Listing Rules and the Act;4. Disclosure Officer 4.1 The board has appointed the Company Secretary to act as the Disclosure Officer. 4.2 The following matters are reserved for the board of directors: (a) deciding if information should be disclosed to ASX in accordance with paragraph 5 and subject to any decision of the board;4.3 The Disclosure Officer is responsible for: (a) ensuring compliance with continuous disclosure obligations;4.4 The Disclosure Officer must maintain a file (Disclosure File) of: (a) material disclosed to ASX;4.5 The Disclosure Officer must report the information referred to in paragraph 4.4 to the board of directors at each Board meeting. 5. Deciding if information should be disclosed 5.1 The Disclosure Officer is responsible for deciding if information should be disclosed, in accordance with paragraphs 5.2 to 5.4. All potentially price-sensitive information must be given to the Disclosing Officer or the Chairman of the board of directors (if the Disclosure Officer is unavailable). 5.2 If the board of directors decides information is price-sensitive and must be disclosed, the Disclosure Officer must: (a) write to ASX disclosing the information; and5.3 If the board of directors cannot reach consensus as to whether information is price-sensitive or if it must be disclosed, the board of directors must refer the matter to the Chairman of the board of directors who will, if necessary, seek external legal or financial advice. If the Chairman decides that the information is price-sensitive, the Disclosure Officer must: (a) write to ASX disclosing the information; and5.4 If the board of directors decides information is not price-sensitive, or does not have to be disclosed, the Disclosure Officer must: (a) make careful notes setting out:5.5 If an officer or employee is in doubt about whether information is potentially price-sensitive, he or she must immediately give the information to the Disclosure Officer or another member of the board of directors (if the Disclosure Officer is unavailable).(i) how the information came to their attention; and(b) place those notes on the Disclosure File. 6. Assessing if information is price-sensitive 6.1 The guiding principle is that the Company must immediately disclose to ASX any information concerning the Group that a reasonable person would expect to have a material effect on the price or value of Company Securities. 6.2 If information would, or would be likely to, influence persons who commonly invest in securities in deciding whether to acquire or dispose of Company Securities, it is material. However, information could be material in other ways. If there is any doubt, the information should be disclosed to the Disclosure Officer or another member of the board of directors (if the Disclosure Officer is unavailable). 6.3 Examples of the types of information that may need to be disclosed include: (a) a change in revenue, or profit or loss, forecasts;6.4 There are many other types of information that could give rise to a disclosure obligation. For example, a development in a company affiliated with, but not controlled by, the Company may be price-sensitive when related to the Company itself. 7. Exception to disclosure The Company does not have to give ASX information if: (a) a reasonable person would not expect the information to be disclosed;8. False markets, market speculation and rumours 8.1 Market speculation and rumours, whether substantiated or not, have the potential to impact on the Company. Speculation may also contain factual errors that could materially affect the Company. 8.2 The board of directors will monitor movements in the price or trading of Company Securities to identify circumstances where a false market may have emerged in Company Securities. 8.3 If ASX asks the Company to give it information to correct or prevent a false market, the Disclosure Officer is responsible for giving the information to ASX after following the procedure in paragraph 5. 8.4 The Group's general policy on responding to market speculation and rumours is that it does not respond to market speculation or rumours. However, the board of directors may decide to make a statement in response to market speculation or rumours if: (a) it considers it is obliged at that time to make a statement to the market about a particular matter; orto prevent or correct a false market occurring in Company Securities. 9. Public release of disclosed information 9.1 The Company will publicly release all information disclosed to ASX under this protocol by placing it on its website. 9.2 The Disclosure Officer must confirm that the Company has received confirmation from ASX that the information has been released to the market, before publicly releasing the information. 10. Trading halts 10.1 The Company may ask ASX to halt trading in Company Securities to: (a) maintain orderly trading in its securities; and10.2 The board of directors will make all decisions about trading halts. 10.3 Employees may only ask ASX for a trading halt if the board of directors approves. 11. Authorised spokespersons 11.1 Only the following persons may speak on behalf of the Group to institutional investors, stockbroking analysts and the media: (a) The Chairman;11.2 Those persons may only clarify information that the Company has publicly released and must not comment on price-sensitive information that has not been released to the market. 11.3 The Group will not expressly or implicitly give institutional investors or stockbroking analysts earnings forecast guidance that has not been released to the market. 11.4 If other employees are asked to comment by an external investor, stockbroking analyst or the media in relation to any matter concerning the Group they must: (a) say that they are not authorised to speak on behalf of the Company; and11.5 Before any media release can be issued the Disclosure officer must: (a) review it;12. Open briefings to institutional investors and stockbroking analysts 12.1 The Company may hold open briefings with institutional investors or stockbroking analysts to discuss information that has been released to the market. 12.2 For the purposes of this protocol: (a) public speeches and presentations by the managing director or chief financial officer are open briefings; and12.3 Price-sensitive information that has not been released to the market must not be disclosed at open briefings. 12.4 If a question raised in a briefing can only be answered by disclosing price-sensitive information, employees must: (a) decline to answer the question; or12.5 If an employee participating in a briefing thinks that something has been raised that might be price-sensitive information that has not been publicly released, he or she must immediately inform the Disclosure Officer or any member of the board of directors (if the Disclosure Officer is unavailable). 12.6 Before any open briefing, the Company will inform the market about the briefing through ASX and on the Company's website. 13. One-on-one briefings with institutional investors and stockbroking analysts 13.1 It is in the interests of shareholders that institutional investors and stockbroking analysts have a thorough understanding of the Group's business, operations and activities. 13.2 The Company may hold one-on-one briefings with institutional investors and stockbroking analysts. At these briefings, the Company may give background and technical information to help institutional investors and stockbroking analysts better understand its business operations and activities. 13.3 For the purposes of this protocol, a one-on-one meeting includes any communication between the Company and an institutional investor or a stockbroking analyst. 13.4 Price-sensitive information that has not been released to the market must not be disclosed at one-on-one briefings. 13.5 File notes must be made of all one-on-one briefings and kept for a reasonable period. 13.6 If an employee participating in a one-on-one briefing thinks that something has been raised that might be price-sensitive information that has not been publicly released, he or she must immediately inform the Disclosure Officer or another member of the board of directors (if the Disclosure Officer is unavailable). 13.7 Before any series of one-on-one meetings, the Company will inform the market about the one-on-one briefings through ASX and on its website. 14. Presentational and briefing materials Any presentational or briefing materials for open or one-on-one briefings must be given to the Disclosure Officer before the briefing to determine if they contain any price-sensitive information that has not been released to the market. 15. 'Blackout' periods To protect against inadvertent disclosure of price-sensitive information, the Company will not hold one-on-one and open briefings (except to deal with matters subject to an announcement through the ASX) between: (a) the end of its financial reporting periods and the announcement of results to the market; and16. Review of reports by analysts 16.1 The Group is not responsible for, and does not endorse, reports by analysts commenting on the Company. 16.2 The Group does not incorporate reports of analysts in its corporate information, including its website (this also extends to hyperlinks to websites of analysts). 16.3 If an analyst sends a draft report to the Group for comment: (a) employees must immediately send it to Disclosure Officer;16.4 Any correction of a factual inaccuracy does not imply that the Group endorses a report. 16.5 A standard disclaimer will be made in any response to an analyst. 17. Informing employees 17.1 This protocol or a summary of it will be distributed to employees to help them understand the Company's continuous disclosure obligations, their individual reporting responsibilities and the need to keep the company's information confidential. 17.2 The Group's share trading policy will also be distributed to the employees. That policy also relates to the treatment of price-sensitive information. 18. Protocol breaches If an employee breaches this protocol, he or she may face disciplinary action, including dismissal in serious cases. 19. Questions Any questions about the Company's continuous disclosure obligations or this protocol should be referred to the Disclosure Officer. 20. Review and changes 20.1 The board of directors will review this protocol as often as it considers necessary. 20.2 The board may change this protocol form time to time by resolution. |